Key indicators: single-crystal X-ray study; T = 293 K; mean (C-C) = 0.006 Å; disorder in main residue; R factor = 0.035; wR factor = 0.071; data-to-parameter ratio = 18.1.
In the title complex, {[CdI 2 (C 11 H 10 N 4 )]ÁC 3 H 7 NO} n , the Cd II ion is four-coordinated by two N atoms from two 1-[(1H-benzimidazol-1-yl)methyl]-1H-imidazole (bmi) ligands and by two terminal I À anions in a distorted tetrahedral geometry. One of the two I À anions is disordered over two sets of sites, with refined occupancies of 0.66 (5) and 0.34 (5). The Cd II ions are bridged by bmi ligands, leading to the formation of a chain along [001] . Dimethylformamide solvent molecules are located between these chains. Classical N-HÁ Á ÁO hydrogen bonding between the bmi ligands and the solvent molecules leads to a consolidation of the structure. 
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Experimental
Crystal data [CdI 2 (C 11 Table 1 Hydrogen-bond geometry (Å , ). C 3 H 7 NO} n , of which the crystal structure is reported herein.
As shown in Figure 1 
The ligand 1-[(1H-benzimidazole-1-yl)methyl]-1H-1,3-imidazole (0.1 mmol) in methanol (4 ml) was added dropwise to an aqueous solution (2 ml) of cadmium iodide (0.1 mmol). The resulting solution was allowed to stand at room temperature.
After four weeks colourless crystals of good quality were obtained from the filtrate and dried in air.
Refinement
The disordered iodine atom was modeled by splitting the atom into two components (I1 and I1'), the site occupation factors of which refined in a ratio of 0.66 (5) supplementary materials
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